First-in-man phase I study assessing the safety and pharmacokinetics of a 1-hour intravenous infusion of the doxorubicin prodrug DTS-201 every 3 weeks in patients with advanced or metastatic solid tumours
Schöffski, Patrick, Delord, Jean-Pierre, Brain, Etienne, Robert, Jacques, Dumez, Herlinde, Gasmi, Jamal, Trouet, AndréVolume:
86
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2017.09.009
Date:
November, 2017
File:
PDF, 924 KB
english, 2017